On the historic occasion of the 122nd shattuck lecture and the 200th anniversary of the New England Journal of Medicine, we chose to address a topic that is at once scientific and personally historic. In recent debates over legalizing marijuana, from all-out acceptance in Colorado to narrow decriminalization in Maryland, the scientific question of the role of marijuana as a gateway drug (i.e., a drug that lowers the threshold for addiction to other agents) has loomed large. Both opponents and proponents of legalization have distorted what science does and does not tell us -and both sides have overlooked the importance of nicotine as a gateway drug.Epidemiologic studies have shown that nicotine use is a gateway to the use of marijuana and cocaine in human populations. What has not been clear is how nicotine accomplishes this. In this article, we describe how our personal collaboration allowed us to bring the techniques of molecular biology to bear on this question and to reveal the action of nicotine in the brain of mice. We then apply our conclusions to the public health concerns that are being raised as the popularity of electronic cigarettes (e-cigarettes) has soared. In the process, we show the potential benefits to society of translating epidemiologic findings into public health policy.
GATEWAY HYPOTHESIS AND THE COMMON LIABILITY MODELThe gateway hypothesis was developed by Denise Kandel, who observed that young people become involved in drugs in stages and sequences. 1 She found that in the general population of the United States and other Western societies, a well-defined developmental sequence of drug use occurs that starts with a legal drug and proceeds to illegal drugs. Specifically, the use of tobacco or alcohol precedes the use of marijuana, which in turn precedes the use of cocaine and other illicit drugs. [1][2][3][4][5][6] Thus, in 2012, among U.S. adults 18 to 34 years of age who had ever used cocaine, 87.9% had smoked cigarettes before using cocaine, 5.7% began using cigarettes and cocaine at the same time, 3.5% used cocaine first, and 2.9% had never smoked cigarettes. Copyright © 2014 Massachusetts Medical Society. Address reprint requests to Dr. E. Kandel at the Department of Neuroscience, College of Physicians and Surgeons, Columbia University, 1051 Riverside Dr., Unit 87, New York, NY 10032, or at erk5@columbia.edu. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. An alternative to the gateway hypothesis has been proposed on the basis of the idea that the use of multiple drugs reflects a common liability for drug use and that addiction, rather than the use of a particular drug, increases the risk of progressing to the use of another drug. 2,[7][8][9][10] Population studies have shown both generalized risk across substances and substancespecific risk -in particular, risk attributable to tobacco use. 11 Although epidemiologic studies can establish the sequence in which different substances are used and can specify their associations, such...